サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1518225

先進治療医薬品開発製造受託機関（CDMO）の世界市場レポート 2024年

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024
出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.40円
先進治療医薬品開発製造受託機関（CDMO）の世界市場レポート 2024年
出版日: 2024年07月22日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

先進治療医薬品開発製造受託機関（CDMO）市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR16.8%で98億5,000万米ドルに成長します。予測期間の成長は、CDMOによる多額の投資、細胞・遺伝子治療（CGT）分野における多数のプレイヤーの出現、細胞・遺伝子治療開発のための助成金や投資の増加、医薬品研究開発費の増加、ATMPの臨床試験数の増加などに起因すると考えられます。この期間の主な動向としては、AAVバイオ製造施設の進歩、細胞・遺伝子治療製造能力の拡大、細胞・遺伝子治療プロセスの技術進歩、高度なプラットフォームや技術へのアクセスに対するニーズの高まり、CRISPRや次世代シーケンサーなどの高度技術の統合による精度向上などが挙げられます。

先進治療医薬品CDMO市場の成長は、臨床試験の増加によって促進されると予想されます。臨床試験とは、医薬品、治療、機器、予防措置などの医療介入の安全性と有効性を評価するためにヒトを対象に実施される調査研究であり、革新的な治療に対する需要の高まりに対応し、世界の疾病負担の増大に取り組むために増加傾向にあります。先進治療医薬品の利用は、専門的な専門知識とインフラを活用するCDMO製造サービスへの需要の高まりにつながります。臨床試験データは、製造プロセスの最適化、拡張性の確保、品質の維持に役立ち、より大きな臨床的・商業的需要に応えることができます。例えば、英国を拠点とする業界団体である英国製薬工業協会は2023年11月、英国で開始された臨床試験の業界全体の年間件数が4.3%増加し、2021年の394件から2022年には411件に増加すると報告しています。このように、臨床試験数の増加が先進治療医薬品CDMO市場の成長を後押ししています。

先進治療医薬品CDMO市場の主要企業は、細胞治療製造における重要な問題に対処し、パートナーの開発活動を加速するために、先進的な細胞治療製造サービスの開発に注力しています。開発・製造受託機関が提供するこれらの細胞療法製造サービスは、初期の前臨床開発から後期の臨床試験、商業化までのサービスを包含しています。例えば、2024年1月、イスラエルを拠点とする細胞ソリューションを専門とするバイオテクノロジー企業Pluristem Therapeutics Inc.は、細胞治療製造サービスを提供する新事業部門PluriCDMOを発表しました。PluriCDMOは、3D細胞増殖を可能にする特許取得済みのバイオリアクターシステムを利用し、幹細胞、人工多能性幹細胞、エクソソーム、免疫療法など様々な細胞タイプの製造を容易にします。PluriCDMOは、適正製造基準（GMP）の範囲内で、スケーラブルかつ費用対効果の高い方法でバッチ間の一貫性を確保しながら、高品質の医薬品を患者に届けることを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場の実績：規模と成長, 2018-2023
  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 遺伝子治療
  • 細胞療法
  • 組織工学
  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：フェーズ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV
  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 腫瘍学
  • 心臓病学
  • 中枢神経系と筋骨格系
  • 感染症
  • 皮膚科
  • 内分泌、代謝、遺伝
  • 免疫学と炎症
  • 眼科
  • 血液学

第7章 地域別・国別分析

  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の先進治療医薬品開発製造受託機関（CDMO）市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 先進治療医薬品開発製造受託機関（CDMO）市場：競合情勢
  • 先進治療医薬品開発製造受託機関（CDMO）市場：企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Resonac Corporation
    • Lonza Group AG
    • Catalent Inc.

第31章 その他の大手企業と革新的企業

  • Charles River Laboratories International Inc.
  • Recipharm AB
  • KBI Biopharma
  • Takara Bio Inc.
  • Rentschler Biopharma SE
  • Ajinomoto Co. Inc.
  • ElevateBio LLC
  • Fujifilm Diosynth Biotechnologies
  • Axplora Group GmbH
  • WuXi Advanced Therapies Inc.
  • Celonic Group
  • Batavia Biosciences B.V.
  • BioCentriq
  • Cytovance Biologics
  • Andelyn Biosciences

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18270

An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that aids in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to offer the expertise, infrastructure, and resources necessary for the development and production of these advanced therapies.

The main types of products handled by advanced therapy medicinal product CDMOs include gene therapy, cell therapy, and tissue-engineered products. Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This process can utilize viral or non-viral vectors to deliver therapeutic genes to target cells across various phases, such as phase I, phase II, phase III, and phase IV clinical trials. These therapies address a range of indications, including oncology, cardiology, central nervous system and musculoskeletal conditions, infectious diseases, dermatology, endocrine and metabolic disorders, genetic diseases, immunology and inflammation, ophthalmology, and hematology.

The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides advanced therapy medicinal products contract development and manufacturing organization (CDMO) market statistics, including the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with advanced therapy medicinal products contract development and manufacturing organization (CDMO) market share, detailed advanced therapy medicinal products contract development and manufacturing organization (CDMO) market segments, market trends, and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) industry. These advanced therapy medicinal products contract development and manufacturing organization (CDMO) market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $4.55 billion in 2023 to $5.30 billion in 2024 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to the increasing number of ATMP clinical trials, growing awareness and confidence among researchers about the benefits of advanced therapy, the presence of numerous ATMP CDMOs, increased efforts to develop novel therapies for various diseases, and supportive government initiatives.

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $9.85 billion in 2028 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to the substantial investment by CDMOs, the emergence of numerous players in the cell and gene therapy (CGT) sector, rising grants and investments for the development of cell and gene therapies, increased pharmaceutical R&D spending, and a growing number of clinical trials for ATMPs. Major trends during this period include advancements in AAV biomanufacturing facilities, expansion of cell and gene therapy manufacturing capabilities, technological advancements in cell and gene therapy processes, an increased need for access to advanced platforms and technologies, and the integration of advanced technologies such as CRISPR and next-generation sequencing to enhance accuracy.

The growth of the advanced therapy medicinal products CDMO market is anticipated to be propelled by the increasing number of clinical trials. Clinical trials, which are research studies conducted in humans to assess the safety and efficacy of medical interventions such as drugs, treatments, devices, or preventive measures, are on the rise to meet the growing demand for innovative treatments and to tackle the increasing global disease burden. The utilization of advanced therapy medicinal products leads to a heightened demand for CDMO manufacturing services, which leverage specialized expertise and infrastructure. Clinical trial data assists in optimizing manufacturing processes, ensuring scalability, and maintaining quality to meet larger clinical and commercial demands. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported a marginal increase of 4.3% in the overall number of industry clinical trials initiated in the UK per year, rising from 394 in 2021 to 411 in 2022. Thus, the escalating number of clinical trials is propelling the growth of the advanced therapy medicinal products CDMO market.

Major players in the advanced therapy medicinal products CDMO market are focusing on developing advanced cell therapy manufacturing services to address critical issues in cell therapy manufacturing and accelerate the development activities of their partners. These cell therapy manufacturing services, offered by contract development and manufacturing organizations, encompass services ranging from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company specializing in cell solutions, introduced PluriCDMO, a new business division offering cell therapy manufacturing services. PluriCDMO utilizes a patented bioreactor system enabling 3D cell multiplication, facilitating the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aims to deliver high-quality medicines to patients while ensuring batch-to-batch consistency in a scalable and cost-effective manner within good manufacturing practice settings.

In February 2022, Recipharm AB, a Sweden-based contract development and manufacturing organization (CDMO), acquired Vibalogics for an undisclosed sum. This acquisition is intended to bolster Recipharm's presence in advanced therapy medicinal products and enable expansion into additional biologic modalities such as viral vectors. The acquisition will allow Recipharm to broaden its technologies and modalities, positioning it to better serve the growing demand for specialist CDMO capabilities in viral manufacturing within the rapidly expanding biopharmaceutical industry. Vibalogics is a Germany-based virotherapy CDMO specializing in manufacturing oncolytic viruses, viral vaccines, and gene therapies.

Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc. , Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market includes revenues earned by entities by providing services such as process development, analytical method development, good manufacturing practice manufacturing, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products CDMO market also includes sales of bioreactors and fermenters, cryopreservation equipment, and laboratory instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced therapy medicinal products contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced therapy medicinal products contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Gene Therapy; Cell Therapy; Tissue Engineered
  • 2) By Phase: Phase I; Phase II; Phase III; Phase IV
  • 3) By Indication: Oncology; Cardiology; Central Nervous System And Musculoskeletal; Infectious Disease; Dermatology; Endocrine, Metabolic, Genetic; Immunology And Inflammation; Ophthalmology; Hematology
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Resonac Corporation; Lonza Group AG; Catalent Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size and Growth

  • 5.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

  • 6.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gene Therapy
  • Cell Therapy
  • Tissue Engineered
  • 6.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Central Nervous System And Musculoskeletal
  • Infectious Disease
  • Dermatology
  • Endocrine, Metabolic, Genetic
  • Immunology And Inflammation
  • Ophthalmology
  • Hematology

7. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

  • 7.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 8.1. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 9.1. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 9.2. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 10.1. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 11.1. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 11.2. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 12.1. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 13.1. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 14.1. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 14.2. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 15.1. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 15.2. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 16.1. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 17.1. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 18.1. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 19.1. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 20.1. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 21.1. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 21.2. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 22.1. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 23.1. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 23.2. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 24.1. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 24.2. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 25.1. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 25.2. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 26.1. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 26.2. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 27.1. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 28.1. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 28.2. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

  • 29.1. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview
  • 29.2. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

  • 30.1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
  • 30.2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Resonac Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lonza Group AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Catalent Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories International Inc.
  • 31.2. Recipharm AB
  • 31.3. KBI Biopharma
  • 31.4. Takara Bio Inc.
  • 31.5. Rentschler Biopharma SE
  • 31.6. Ajinomoto Co. Inc.
  • 31.7. ElevateBio LLC
  • 31.8. Fujifilm Diosynth Biotechnologies
  • 31.9. Axplora Group GmbH
  • 31.10. WuXi Advanced Therapies Inc.
  • 31.11. Celonic Group
  • 31.12. Batavia Biosciences B.V.
  • 31.13. BioCentriq
  • 31.14. Cytovance Biologics
  • 31.15. Andelyn Biosciences

32. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking

33. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

35. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Future Outlook and Potential Analysis

  • 35.1 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer